CD8A and ovarian cancer: Adams et al. [36] showed that ovarian cancer patients who have tumors with a high frequency of intraepithelial T cells, specifically CD8+ T cells, have a significantly better 5-year survival rate than patients whose tumors have a low frequency of intraepithelial CD8+ T cells.